HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural and organic market reaches $465 mil.

This article was originally published in The Rose Sheet

Executive Summary

The natural and organic personal-care market has grown over 35% since 2005 and is now valued at $465 mil., market researcher Mintel says June 10. "The recent drive toward healthy and green living has consumers placing a high degree of trust in the 'all-natural' claim for personal-care products," Mintel Senior Analyst Christopher Haack says. Women and Hispanics are key drivers of the trend, with natural and organic products comprising 74% of Hispanics' personal-care purchases, Mintel says. Mainstream companies are using natural ingredients and opting to certify their products as organic or natural in order to differentiate from competition, the researcher notes. Walgreens and Target have inked exclusive distribution deals with natural and organic marketers Yes To Carrots and Erbaviva, respectively. Mintel has identified a 53% increase in new organic or all-natural launches in the past two years - from 554 in 2005 to 846 in 2007...

You may also be interested in...



Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation

Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel